Prospective approaches to enhancing CAR T cell therapy for glioblastoma

Glioblastoma (GBM) is the most common malignant brain tumor. The poor clinical outcome and overall ineffectiveness of current standard treatments, including surgery, chemotherapy, and radiation, highlight the urgent need for alternative tumor-specific therapies for GBM. Chimeric antigen receptor (CA...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Sun Il, Yin, Jinlong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582117/
https://www.ncbi.nlm.nih.gov/pubmed/36275671
http://dx.doi.org/10.3389/fimmu.2022.1008751

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582117/
https://www.ncbi.nlm.nih.gov/pubmed/36275671
http://dx.doi.org/10.3389/fimmu.2022.1008751

Ejemplares similares